1. Home
  2. CPHI vs ACXP Comparison

CPHI vs ACXP Comparison

Compare CPHI & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPHI
  • ACXP
  • Stock Information
  • Founded
  • CPHI N/A
  • ACXP 2017
  • Country
  • CPHI China
  • ACXP United States
  • Employees
  • CPHI N/A
  • ACXP N/A
  • Industry
  • CPHI Biotechnology: Pharmaceutical Preparations
  • ACXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • CPHI Health Care
  • ACXP Health Care
  • Exchange
  • CPHI Nasdaq
  • ACXP Nasdaq
  • Market Cap
  • CPHI 7.3M
  • ACXP 8.4M
  • IPO Year
  • CPHI N/A
  • ACXP 2021
  • Fundamental
  • Price
  • CPHI $1.83
  • ACXP $0.43
  • Analyst Decision
  • CPHI
  • ACXP Strong Buy
  • Analyst Count
  • CPHI 0
  • ACXP 2
  • Target Price
  • CPHI N/A
  • ACXP $10.00
  • AVG Volume (30 Days)
  • CPHI 152.1K
  • ACXP 18.4M
  • Earning Date
  • CPHI 08-13-2025
  • ACXP 08-08-2025
  • Dividend Yield
  • CPHI N/A
  • ACXP N/A
  • EPS Growth
  • CPHI N/A
  • ACXP N/A
  • EPS
  • CPHI N/A
  • ACXP N/A
  • Revenue
  • CPHI $4,295,377.00
  • ACXP N/A
  • Revenue This Year
  • CPHI N/A
  • ACXP N/A
  • Revenue Next Year
  • CPHI N/A
  • ACXP N/A
  • P/E Ratio
  • CPHI N/A
  • ACXP N/A
  • Revenue Growth
  • CPHI N/A
  • ACXP N/A
  • 52 Week Low
  • CPHI $1.20
  • ACXP $0.30
  • 52 Week High
  • CPHI $3.35
  • ACXP $3.33
  • Technical
  • Relative Strength Index (RSI)
  • CPHI 52.11
  • ACXP 47.99
  • Support Level
  • CPHI $1.55
  • ACXP $0.52
  • Resistance Level
  • CPHI $1.91
  • ACXP $0.63
  • Average True Range (ATR)
  • CPHI 0.18
  • ACXP 0.09
  • MACD
  • CPHI 0.02
  • ACXP 0.00
  • Stochastic Oscillator
  • CPHI 61.38
  • ACXP 17.33

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

Share on Social Networks: